Witkiewicz, A. K., Cox, D., & Knudsen, E. S. (2014). CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models. Impact Journals LLC.
シカゴスタイル引用形Witkiewicz, Agnieszka K., Derek Cox, , Erik S. Knudsen. CDK4/6 Inhibition Provides a Potent Adjunct to Her2-targeted Therapies in Preclinical Breast Cancer Models. Impact Journals LLC, 2014.
MLA引用形式Witkiewicz, Agnieszka K., Derek Cox, , Erik S. Knudsen. CDK4/6 Inhibition Provides a Potent Adjunct to Her2-targeted Therapies in Preclinical Breast Cancer Models. Impact Journals LLC, 2014.
警告: この引用は必ずしも正確ではありません.